Skip to main navigation
MIRUM

Header Menu

  • Who We Are
    • About Mirum
    • Leadership
    • Board of Directors
  • Programs
    • Pipeline
    • Maralixibat
    • Volixibat
    • Publications & Presentations
  • Patients & Families
    • Clinical Trials
    • Expanded Access
    • Progressive Familial Intrahepatic Cholestasis (PFIC)
    • Alagille Syndrome (ALGS)
    • Biliary Atresia (BA)
    • Intrahepatic Cholestasis of Pregnancy (ICP)
    • Primary Sclerosing Cholangitis (PSC)
  • Investors & Media
    • News Releases
    • Events and Presentations
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management
      • Committee Composition
    • Financials & Filings
      • SEC Filing
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
    • Shareholder Services
      • Investor FAQs
      • Email Alerts
      • Contact IR
  • Careers
  • Contact Us
  • Menu

Investor Relations

  • News Releases
  • Events and Presentations
  • Corporate Governance
    • Documents & Charters
    • Board of Directors
    • Management
    • Committee Composition
  • Financials & Filings
    • SEC Filings
    • Analyst Coverage
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
  • Shareholder Services
    • Investor FAQs
    • Contact IR
    • Email Alerts

Investor Tools

  • Print

    Print

  • RSS Feeds

    RSS Feeds

  • Email Alerts

    Email Alerts

  • Search

    Search

  • Contact IR

    Contact IR

  • Email Page

    Email Page

SEC Filings

SEC Filings

Filing date Form Description Filing Group Issuer View
Feb 16, 2021 SC 13G/A

An amendment to the SC 13G filing

Other
Mirum Pharmaceuticals, Inc.
0001172661-21-000754.pdf
0001172661-21-000754.rtf
0001172661-21-000754.xls
View HTML
Jan 27, 2021 SC 13G/A

An amendment to the SC 13G filing

Other
Mirum Pharmaceuticals, Inc.
0001395064-21-000006.pdf
0001395064-21-000006.rtf
0001395064-21-000006.xls
View HTML
Jan 12, 2021 8-K

Report of unscheduled material events or corporate event

Current Reports
Mirum Pharmaceuticals, Inc.
0001193125-21-006844.pdf
0001193125-21-006844.rtf
0001193125-21-006844.xls
View HTML
Jan 11, 2021 4

Statement of changes in beneficial ownership of securities

3,4,5
Mirum Pharmaceuticals, Inc.
0001209191-21-002983.pdf
0001209191-21-002983.rtf
0001209191-21-002983.xls
View HTML
Jan 11, 2021 4

Statement of changes in beneficial ownership of securities

3,4,5
Mirum Pharmaceuticals, Inc.
0001209191-21-002988.pdf
0001209191-21-002988.rtf
0001209191-21-002988.xls
View HTML
Jan 11, 2021 4

Statement of changes in beneficial ownership of securities

3,4,5
Mirum Pharmaceuticals, Inc.
0001209191-21-003002.pdf
0001209191-21-003002.rtf
0001209191-21-003002.xls
View HTML
Jan 11, 2021 4

Statement of changes in beneficial ownership of securities

3,4,5
Mirum Pharmaceuticals, Inc.
0001209191-21-003022.pdf
0001209191-21-003022.rtf
0001209191-21-003022.xls
View HTML
Jan 11, 2021 4

Statement of changes in beneficial ownership of securities

3,4,5
Mirum Pharmaceuticals, Inc.
0001209191-21-003026.pdf
0001209191-21-003026.rtf
0001209191-21-003026.xls
View HTML
Jan 11, 2021 4

Statement of changes in beneficial ownership of securities

3,4,5
Mirum Pharmaceuticals, Inc.
0001209191-21-003030.pdf
0001209191-21-003030.rtf
0001209191-21-003030.xls
View HTML
Dec 30, 2020 D
Other
Mirum Pharmaceuticals, Inc.
0001759425-20-000002.pdf
0001759425-20-000002.rtf
0001759425-20-000002.xls
View HTML

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »
Displaying 1 - 10 of 144 results

Data provided by Kaleidoscope.

Header Menu

  • Who We Are
  • About Mirum
  • Leadership
  • Board of Directors
  • Programs
  • Pipeline
  • Maralixibat
  • Volixibat
  • Publications & Presentations
  • Patients & Families
  • Clinical Trials
  • Expanded Access
  • Progressive Familial Intrahepatic Cholestasis (PFIC)
  • Alagille Syndrome (ALGS)
  • Biliary Atresia (BA)
  • Intrahepatic Cholestasis of Pregnancy (ICP)
  • Primary Sclerosing Cholangitis (PSC)
  • Investors & Media
  • News Releases
  • Events and Presentations
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Shareholder Services
  • Careers
  • Contact Us
© 2021 – Mirum Pharmaceuticals, Inc.
Scroll to top
  • Facebook
  • Twitter
  • LinkedIn